Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.
Open Access
- 1 August 1988
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood
- Vol. 63 (8) , 986-990
- https://doi.org/10.1136/adc.63.8.986
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus diseaseThe Pediatric Infectious Disease Journal, 1987
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionNew England Journal of Medicine, 1986
- Ribavirin aerosol for acute bronchiolitis.Archives of Disease in Childhood, 1986
- Treatment of Respiratory Viral Infection in an Immunodeficient Infant With Ribavirin AerosolArchives of Pediatrics & Adolescent Medicine, 1984
- Ribavirin Aerosol Treatment of Bronchiolitis Associated with Respiratory Syncytial Virus Infection in InfantsPediatrics, 1983
- RIBAVIRIN TREATMENT OF VIRAL PNEUMONITIS IN SEVERE COMBINED IMMUNODEFICIENCY DISEASEThe Lancet, 1983
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982
- Neonatal Respiratory Syncytial Virus InfectionNew England Journal of Medicine, 1979
- Respiratory Syncytial Virus Infection of the NewbornBMJ, 1970